Telehealth Ledger
Enhance.MD logoProvider treatment guide · checked 26 October 2026

Enhance.MD Tirzepatide

Published by Telehealth LedgerSource checked 26 October 2026

Enhance.MD lists GLP-1 Advanced (tirzepatide) 1-month at $329 every 4 weeks after $279 for the first period; $357.40 annualized monthly equivalent (365-day basis). Medication is included in that catalog price. Readers considering Enhance.MD for compounded tirzepatide who need the 1-month card isolated from prepaid 12-month figures and from the Elite combination listing. The commercial terms were checked 26 October 2026; state access, clinician approval, dispensing details, and personal suitability remain separate questions.

We may earn a commission if you start a program through links on this page. It doesn't change prices or how we sort them. Disclosure

Visit Enhance.MD Affiliate link · we may earn a commissionRead the full review
Enhance.MD Tirzepatide treatment illustration
$329every 4 weeks after $279 for the first period; $357.40 annualized monthly equivalent (365-day basis)
Includedmedication in published price
Once-weekly subcutaneous injection, billed every 4 weekslisted format
26 October 2026commercial terms checked
10 listed restrictionspublished state availability

Who this offer may suit commercially: Enhance.MD Tirzepatide

Evaluate Enhance.MD's 1-month GLP-1 Advanced tirzepatide offer on its own $329 charge billed every 4 weeks, without treating Elite combination or microdosing SKUs as the same product.

Readers considering Enhance.MD for compounded tirzepatide who need the 1-month card isolated from prepaid 12-month figures and from the Elite combination listing. This guide stays at the Enhance.MD Tirzepatide offer because a provider-wide reputation cannot answer a product-specific price or route question.

The product identity check: GLP-1 Advanced (tirzepatide) 1-month

GLP-1 Advanced (tirzepatide) 1-month is listed as a compounded product in Once-weekly subcutaneous injection, billed every 4 weeks format. FDA states that compounded drugs are not FDA-approved and do not receive the same premarket review as approved drug products. Ask for the exact formulation and dispensing pharmacy before purchase. That status is central to this Enhance.MD guide because a related medication name does not make branded, compounded, oral, nasal, and injectable products interchangeable.

Enhance.MD lists GLP-1 Advanced (tirzepatide) 1-month in Once-weekly subcutaneous injection, billed every 4 weeks format. The Compounded tirzepatide injection comparison groups offers with the same treatment and route so their prices can be assessed fairly. A shared medication name does not make different formulations interchangeable. This guide does not provide dose instructions or route conversions, and it does not establish that another formulation has the same evidence, safety profile, convenience or outcomes.

What the published number means: Enhance.MD

Enhance.MD lists GLP-1 Advanced (tirzepatide) 1-month at $329 every 4 weeks after $279 for the first period; $357.40 annualized monthly equivalent (365-day basis), checked 26 October 2026. Read the amount together with the billing interval and any promotion or prepayment shown beside it. A lower monthly equivalent may require a longer commitment and a larger charge today. The linked price source is dated evidence of the advertised offer, not an independently verified checkout total or a guarantee that every dose and plan costs the same.

The published price includes medication. It does not verify that labs, every consultation, supplies, expedited shipping, or future dose changes are included unless the source says so. Those items remain checkout questions. For Enhance.MD Tirzepatide, read medication inclusion as one part of the offer, not as proof that every service surrounding the prescription is free. The dated source establishes the advertised basis; it does not independently audit the final checkout, dispensing event, or quality of care.

Provider structure and operating terms: Enhance.MD

The linked sources identify Enhance Wellness, PC; EnhanceMD CA, PC; iThriveMD, PC as Enhance.MD's medical group. Quoted from the terms: healthcare services are delivered through Enhance Wellness, PC, EnhanceMD CA, PC, and iThriveMD, PC. The homepage names Enhance Wellness PC and iThriveMD PC as the practices the platform supports. These entities can perform different jobs, so the consumer-facing brand should not automatically be described as the clinician or dispensing pharmacy for Tirzepatide.

Onboarding ineligibility refund; no prescription returns: Quoted from how-it-works: "If at any point during the onboarding process you are found ineligible for our formulation, Enhance.MD will provide a full refund of 100% of your initial payment." The shipping page says prescription products cannot be returned for any reason. An unresolved issue for Enhance.MD's Tirzepatide offer remains: Sitewide $150-off banner is not the product-page first-order amounts: A sitewide banner reads "up to $150 off your first order," while Core and Advanced plan cards show $50 off the 1-month term and $100 off first order on 3-, 6-, and 12-month terms. No $150 checkout reduction is published on those product pages. Ask the provider how that issue affects the selected order. A published price does not resolve uncertainty about billing, fulfillment, eligibility or the terms that apply after payment.

What checkout can change: Enhance.MD Tirzepatide

The published offer lists $329 every 4 weeks after $279 for the first period; $357.40 annualized monthly equivalent (365-day basis). It does not establish every possible dose, renewal, refund, or future price. Confirm the complete checkout total and next billing date before payment. For Enhance.MD's Tirzepatide offer, distinguish the introductory charge, continuing charge, upfront payment and required commitment. A monthly equivalent can be useful, but only when the required payment and term remain visible beside it.

The Enhance.MD price source for this offer was checked on 26 October 2026. Before paying for Tirzepatide, compare the amount charged today with the amount charged later, the number of months purchased, the renewal date, the cancellation window, and the refund boundary after clinical or pharmacy processing. A published price cannot safely answer those policy questions unless the cited provider evidence does.

Confirm where this treatment is available: Tirzepatide

Published availability lists Alabama, Arkansas, Georgia, Hawaii, Louisiana, Missouri, Mississippi, North Dakota, South Carolina and Tennessee as restricted for weight-loss programs. That list reflects the sources checked on the date shown; it does not prove eligibility everywhere else. Confirm the current state rule before intake. The Tirzepatide access check belongs near the price because a low published figure has little decision value when Enhance.MD cannot serve the reader's state or the selected product cannot be fulfilled there.

For Enhance.MD Tirzepatide, the consumer brand, administrative platform, clinical group, and dispensing pharmacy can be different entities. A provider page may describe a national service while licensure, product rules, and pharmacy coverage narrow actual fulfillment. Ask which clinician entity would review the intake and which licensed pharmacy would dispense this exact product in the reader's state before treating access as settled.

Where this offer belongs in the market: Tirzepatide

The linked Tirzepatide comparison places Enhance.MD beside other providers with published prices. Check the same details for every offer: continuing price, introductory period, required prepayment, medication inclusion, product type, delivery format, verification date, and state evidence. If two offers use different routes or one price excludes medication, a simple lowest-number verdict would not be a like-for-like conclusion.

Use the comparison link to check other Tirzepatide offers, then open Enhance.MD's site to confirm the selected product. A provider may list several related treatments or plan lengths on the same page. Make sure the intake and checkout still name GLP-1 Advanced (tirzepatide) 1-month, use the once-weekly subcutaneous injection, billed every 4 weeks format, and show the same medication inclusion and billing basis before treating the two offers as equivalent.

A disciplined next step: Enhance.MD Tirzepatide

The strongest reason to keep Enhance.MD on a Tirzepatide shortlist is transparency about the published offer: product, format, price basis, inclusion, and check date can all be named. Unknown pharmacy or policy details still reduce certainty.

Readers considering Enhance.MD for compounded tirzepatide who need the 1-month card isolated from prepaid 12-month figures and from the Elite combination listing. The next step is to compare only matching Tirzepatide records and then ask Enhance.MD to resolve every unknown that would change total cost or fulfillment.

Common questions

Enhance.MD Tirzepatide FAQ

How should the price be read for Enhance.MD Tirzepatide?
The linked price source lists $329 every 4 weeks after $279 for the first period; $357.40 annualized monthly equivalent (365-day basis) for GLP-1 Advanced (tirzepatide) 1-month, checked 26 October 2026. The amount should be read with any introduction, prepayment, or commitment shown in the same offer record. It is a dated published commercial fact, not a promise that every checkout configuration, future renewal, or product change will cost the same amount.
Does the figure include medication in the Enhance.MD figure?
The published Enhance.MD offer includes medication for Tirzepatide. That does not establish that the price includes labs, every consultation, supplies, faster shipping, dose-related price changes, or a future refill. Confirm those items and the complete charge in the selected checkout before treating the figure as all-inclusive.
Why does the format matter for Enhance.MD Tirzepatide?
This guide covers GLP-1 Advanced (tirzepatide) 1-month in Once-weekly subcutaneous injection, billed every 4 weeks format. It does not transfer price, regulatory status, evidence, convenience, dosing, pharmacy, or fulfillment claims to another Tirzepatide formulation or to a related product. Compare route and product identity before comparing the price because similar medication names can still describe materially different offers.
Is nationwide access verified for Enhance.MD Tirzepatide?
Published availability lists Alabama, Arkansas, Georgia, Hawaii, Louisiana, Missouri, Mississippi, North Dakota, South Carolina and Tennessee as restricted for this type of treatment. Confirm eligibility directly because provider coverage can change. A published state list is only one part of eligibility. Enhance.MD must also confirm clinician licensure, product eligibility, and pharmacy fulfillment for the specific Tirzepatide prescription. Completing an intake does not guarantee approval, dispensing, or a particular outcome.
What is the next comparison step for Enhance.MD Tirzepatide?
Use the Tirzepatide comparison to check the dated prices, product formats and plan terms across providers. Compare Enhance.MD only with offers that disclose the same price components, medication inclusion, commitment, and format; otherwise explain why the rows are not directly equivalent.

Sources and method

Telehealth Ledger checked provider pages, plan terms, and independent context on 26 October 2026. This page compares published commercial terms. It is not a rating, medical advice, or a guarantee that a clinician will prescribe treatment.